139 related articles for article (PubMed ID: 17715463)
1. Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function.
Trevisan CP; Pastorello E; Ermani M; Angelini C; Tomelleri G; Tonin P; Mongini T; Palmucci L; Galluzzi G; Tupler RG; Marioni G; Rimini A
Audiol Neurootol; 2008; 13(1):1-6. PubMed ID: 17715463
[TBL] [Abstract][Full Text] [Related]
2. Facioscapulohumeral muscular dystrophy: hearing loss and other atypical features of patients with large 4q35 deletions.
Trevisan CP; Pastorello E; Tomelleri G; Vercelli L; Bruno C; Scapolan S; Siciliano G; Comacchio F
Eur J Neurol; 2008 Dec; 15(12):1353-8. PubMed ID: 19049553
[TBL] [Abstract][Full Text] [Related]
3. Absence of hearing impairment in adult onset facioscapulohumeral muscular dystrophy.
Rogers MT; Zhao F; Harper PS; Stephens D
Neuromuscul Disord; 2002 May; 12(4):358-65. PubMed ID: 12062253
[TBL] [Abstract][Full Text] [Related]
4. Cochlear function in facioscapulohumeral muscular dystrophy.
Balatsouras DG; Korres S; Manta P; Panousopoulou A; Vassilopoulos D
Otol Neurotol; 2007 Jan; 28(1):7-10. PubMed ID: 17106430
[TBL] [Abstract][Full Text] [Related]
5. Infantile facioscapulohumeral muscular dystrophy revisited: Expansion of clinical phenotypes in patients with a very short EcoRI fragment.
Chen TH; Lai YH; Lee PL; Hsu JH; Goto K; Hayashi YK; Nishino I; Lin CW; Shih HH; Huang CC; Liang WC; Wang WF; Jong YJ
Neuromuscul Disord; 2013 Apr; 23(4):298-305. PubMed ID: 23434070
[TBL] [Abstract][Full Text] [Related]
6. Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy.
Pastorello E; Cao M; Trevisan CP
Clin Neurol Neurosurg; 2012 Apr; 114(3):230-4. PubMed ID: 22079131
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy.
Lutz KL; Holte L; Kliethermes SA; Stephan C; Mathews KD
Neurology; 2013 Oct; 81(16):1374-7. PubMed ID: 24042093
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and genetical features of Japanese early-onset facioscapulohumeral muscular dystrophy].
Yamanaka G; Goto K; Hayashi YK; Miyajima T; Hoshika A; Arahata K
No To Hattatsu; 2002 Jul; 34(4):318-24. PubMed ID: 12134683
[TBL] [Abstract][Full Text] [Related]
9. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.
Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S
Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813
[TBL] [Abstract][Full Text] [Related]
10. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S
J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970
[TBL] [Abstract][Full Text] [Related]
11. Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample.
Mostacciuolo ML; Pastorello E; Vazza G; Miorin M; Angelini C; Tomelleri G; Galluzzi G; Trevisan CP
Clin Genet; 2009 Jun; 75(6):550-5. PubMed ID: 19320656
[TBL] [Abstract][Full Text] [Related]
12. FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy.
Felice KJ; North WA; Moore SA; Mathews KD
Neurology; 2000 May; 54(10):1927-31. PubMed ID: 10822431
[TBL] [Abstract][Full Text] [Related]
13. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
[TBL] [Abstract][Full Text] [Related]
14. [Translocation between chromosomes 4q35 and 10q26 in facioscapulohumeral muscular dystrophy].
Su QX; Zhang C; Zeng Y; Lu XL; Liu XR; Wang ZH; Zhu YZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):581-4. PubMed ID: 14650163
[TBL] [Abstract][Full Text] [Related]
15. The auditory, vestibular, and oculomotor system in facioscapulohumeral dystrophy.
Verhagen WI; Huygen PL; Padberg GW
Acta Otolaryngol Suppl; 1995; 520 Pt 1():140-2. PubMed ID: 8749103
[TBL] [Abstract][Full Text] [Related]
16. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms.
Banerji CRS; Cammish P; Evangelista T; Zammit PS; Straub V; Marini-Bettolo C
Neuromuscul Disord; 2020 Apr; 30(4):315-328. PubMed ID: 32327287
[TBL] [Abstract][Full Text] [Related]
17. FSHD-like patients without 4q35 deletion.
Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
[TBL] [Abstract][Full Text] [Related]
18. On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy.
Padberg GW; Brouwer OF; de Keizer RJ; Dijkman G; Wijmenga C; Grote JJ; Frants RR
Muscle Nerve Suppl; 1995; (2):S73-80. PubMed ID: 23573590
[TBL] [Abstract][Full Text] [Related]
19. Inheritance of a 38-kb fragment in apparently sporadic facioscapulohumeral muscular dystrophy.
Vitelli F; Villanova M; Malandrini A; Bruttini M; Piccini M; Merlini L; Guazzi G; Renieri A
Muscle Nerve; 1999 Oct; 22(10):1437-41. PubMed ID: 10487912
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
